Equity Research, Broker Reports, and media content on Oncimmune Holdings Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Oncimmune Holdings Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Oncimmune Holdings Plc

Company Profile

  • Personnel
  • Adam Hill, CEO
  • Matthew Hall, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Oncimmune Holdings Plc. We currently have 78 research reports from 7 professional analysts.

  • Open: 188p
  • Range Today: 186/186p
  • 52 Week: 30.0/200p
  • Daily Volume: 1.4k
  • Daily Liquidity: (0.00%)
  • # Shares: 63.5m
  • Market Cap: £119.4m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
18Jan21 11:37 RNS Holding(s) in Company
14Jan21 09:49 RNS PDMR Dealing
06Jan21 10:27 RNS Total Voting Rights
18Dec20 07:00 RNS PDMR Dealing
15Dec20 07:00 RNS-R Autoantibody profiles publication for RA treatment
14Dec20 07:00 RNS EarlyCDT Lung blood test launch into the NHS
30Nov20 11:21 RNS Results of Annual General Meeting
  • Frequency of research reports


  • Research reports on

    Oncimmune Holdings Plc

  • Providers covering

    Oncimmune Holdings Plc